DMK Gets OK For Ch. 11 Liquidation Plan

By Yun Park · October 28, 2024, 2:43 PM EDT

A Delaware bankruptcy judge approved DMK Pharmaceuticals' Chapter 11 liquidation plan on Monday, resolving objections from the U.S. Trustee's Office and the unsecured creditors' committee, and aiming to settle approximately $15...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Bankruptcy Scorecard

Summary

DMK Pharmaceuticals has applied for Chapter 11 protection in Delaware, citing recent clinical trial failures and product recalls, as well as the government's allegation that a subsidiary engaged in criminal activities, as reasons for seeking bankruptcy relief.

Case Number

24-10153

Judge

Mary F. Walrath

Venue

U.S. Bankruptcy Court for the District of Delaware

Capital Structure

Total Liabilities:

$13.9M

View Full Scorecard

Related Sections

Case Information

Case Title

USA v. US Compounding, Inc.

Case Number

1:24-cr-00423

Court

New York Southern

Nature of Suit

Date Filed

July 09, 2024

Case Title

DMK Pharmaceuticals Corporation

Case Number

1:24-bk-10153

Court

Delaware

Nature of Suit

Date Filed

February 02, 2024

Recent Articles By Yun